Literature DB >> 33927403

'Unprecedented achievement': who received the first billion COVID vaccinations?

Freda Kreier.   

Abstract

Entities:  

Keywords:  SARS-CoV-2; Vaccines

Year:  2021        PMID： 33927403     DOI： 10.1038/d41586-021-01136-2

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  14 in total

1.  Enhancing SARS-CoV-2 surveillance through regular genomic sequencing is an essential element of COVID-19 control in resource-limited settings.

Authors:  Grant Murewanhema; Faith Mutsigiri-Murewanhema; Edward Kunonga
Journal:  Pan Afr Med J       Date:  2022-02-01

2.  Relative Virulence of SARS-CoV-2 Among Vaccinated and Unvaccinated Individuals Hospitalized with SARS-CoV-2.

Authors:  Alicia A Grima; Kiera R Murison; Alison E Simmons; Ashleigh R Tuite; David N Fisman
Journal:  Clin Infect Dis       Date:  2022-05-25       Impact factor: 20.999

Review 3.  The clinical correlates of vaccine-induced immune thrombotic thrombocytopenia after immunisation with adenovirus vector-based SARS-CoV-2 vaccines.

Authors:  Eleanor R Gaunt; Neil A Mabbott
Journal:  Immunother Adv       Date:  2021-08-17

4.  Impact of population mixing between vaccinated and unvaccinated subpopulations on infectious disease dynamics: implications for SARS-CoV-2 transmission.

Authors:  David N Fisman; Afia Amoako; Ashleigh R Tuite
Journal:  CMAJ       Date:  2022-04-25       Impact factor: 16.859

5.  Expert Views on COVAX and Equitable Global Access to COVID-19 Vaccines.

Authors:  Tania Manriquez Roa; Felicitas Holzer; Florencia Luna; Nikola Biller-Andorno
Journal:  Int J Public Health       Date:  2021-12-31       Impact factor: 3.380

Review 6.  Sheet, Surveillance, Strategy, Salvage and Shield in global biodefense system to protect the public health and tackle the incoming pandemics.

Authors:  Xinzi Wang; Tianyun Wu; Luis F S Oliveira; Dayi Zhang
Journal:  Sci Total Environ       Date:  2022-01-29       Impact factor: 10.753

7.  Implementing national COVID-19 vaccination programmes in sub-Saharan Africa- early lessons from Zimbabwe: a descriptive cross-sectional study.

Authors:  Grant Murewanhema; Trouble Victor Burukai; Brighton Chireka; Edward Kunonga
Journal:  Pan Afr Med J       Date:  2021-11-24

8.  Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together.

Authors:  Sudhan Rackimuthu; Kapil Narain; Arush Lal; Faisal A Nawaz; Parvathy Mohanan; Mohammad Yasir Essar; Henry Charles Ashworth
Journal:  Global Health       Date:  2022-02-22       Impact factor: 4.185

9.  A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2.

Authors:  Yaochang Yuan; Xiantao Zhang; Ran Chen; Yuzhuang Li; Bolin Wu; Rong Li; Fan Zou; Xiancai Ma; Xuemei Wang; Qier Chen; Jieyi Deng; Yongli Zhang; Tao Chen; Yingtong Lin; Shumei Yan; Xu Zhang; Congrong Li; Xiuqing Bu; Yi Peng; Changwen Ke; Kai Deng; Ting Pan; Xin He; Yiwen Zhang; Hui Zhang
Journal:  Cell Rep       Date:  2021-12-23       Impact factor: 9.423

10.  COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead.

Authors:  Marguerite Massinga Loembé; John N Nkengasong
Journal:  Immunity       Date:  2021-07-13       Impact factor: 31.745
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.